Yan Shen

Nanjing University

H指数:45

被引数:7,548

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GABARAPL1 drives therapeutic differentiation of cancer cells by targeting epigenetic changes regulated by SFPQ

GABARAPL1通过靶向由SFPQ调控的表观遗传变化来驱动癌细胞的治疗性分化

Pharmacological Research

IF10.5

2026-10-240

OAAI

Construction of a human placental brush border membrane vesicle model for evaluating the effect of antenatal drugs on OCTN1/2 transport function

构建人胎盘刷状缘膜囊泡模型以评估产前药物对OCTN1/2转运功能的影响

Chemico-Biological Interactions

IF5.4

2026-09-120

PRE

Mechanistic insights into cytochrome P450 inhibition by progesterone and its impact on fluoxetine pharmacokinetics

孕酮对细胞色素P450抑制的机制探讨及其对氟西汀药代动力学的影响

Biochemical Pharmacology

IF5.6

2026-08-010

PRE

An exploratory study on predicting HER2-positive expression status of breast cancer using ultrasound radiomics combined with machine learning models

PLOS ONE

IF2.6

2025-10-230

PRE

Optimization of fluorescent silver nanowires for drug loading and release in colorectal Cancer therapy

荧光银纳米线在结直肠癌治疗中药物负载与释放的优化

Chemical Physics Letters

IF3.1

2025-08-060

PRE

Tumor site, stage, and receptor-specific efficacy of radiation therapy in Asian breast cancer patients aged 60 years and older: A SEER database survival analysis incorporating clinicopathological features and nomograms

肿瘤部位、分期及受体特异性放射治疗的疗效：基于SEER数据库的亚洲60岁及以上乳腺癌患者生存分析，纳入临床病理特征及列线图

breast

IF0

2025-06-100

Direct inhibition of the TXNIP-NLRP3-GSDMD pathway reduces pyroptosis in colonocytes and alleviates ulcerative colitis in mice by the small compound PEITC

通过小分子化合物PEITC直接抑制TXNIP-NLRP3-GSDMD通路可减轻结肠细胞焦亡并缓解小鼠的溃疡性结肠炎。

ACTA PHARMACOLOGICA SINICA

IF8.4

2025-04-070

PRE

Natural compound PEITC inhibits gain of function of p53 mutants in cancer cells by switching YAP-binding partners between p53 and p73

天然化合物PEITC通过在p53和p73之间切换YAP结合伴侣，抑制癌细胞中p53突变体的功能获得。

ACTA PHARMACOLOGICA SINICA

IF8.4

2025-02-100

PRE

Tumoral IL-10-activated SHP2 in macrophages promotes mammary carcinoma progression

肿瘤性IL-10激活的SHP2在巨噬细胞中促进乳腺肿瘤进展

Fundamental Research

IF6.3

2024-04-150

OAAI

Evaluation of monkeypox knowledge and attitudes among Chinese medical students

BMC PUBLIC HEALTH

IF3.6

2024-03-084

OAAI

Antibody-Free Fluorine-Assisted Metabolic Sequencing of RNA N 4-Acetylcytidine

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2023-09-2914

PRE

Natural compound fraxinellone ameliorates intestinal fibrosis in mice via direct intervention of HSP47-collagen interaction in the epithelium

ACTA PHARMACOLOGICA SINICA

IF8.4

2023-08-143

PRE

Transcriptome-wide profiling of A-to-I RNA editing by Slic-seq

通过slic-seq对A到I RNA编辑进行全转录组分析

NUCLEIC ACIDS RESEARCH

IF13.1

2023-07-208

OAAI

Utilizing Epigenetic Modification as a Reactive Handle To Regulate RNA Function and CRISPR-Based Gene Regulation

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2023-05-165

PRE

Highly expressed SERCA2 triggers tumor cell autophagy and is a druggable vulnerability in triple-negative breast cancer

ACTA PHARMACEUTICA SINICA B

IF14.6

2022-12-019

OAAI

A plant-derived glucocorticoid receptor modulator with potency to attenuate the side effects of glucocorticoid therapy

一种植物来源的糖皮质激素受体调节剂，具有减轻糖皮质激素治疗副作用的功效

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2022-10-137

OAAI

Chemical Genetics Reveals a Role of Squalene Synthase in TGFβ Signaling and Cardiomyogenesis

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2021-08-265

PREAI

Triggering a switch from basal- to luminal-like breast cancer subtype by the small-molecule diptoindonesin G via induction of GABARAPL1

CELL DEATH & DISEASE

IF9.6

2020-08-1535

OAAI

Discovery, Biosynthesis, and Heterologous Production of Loonamycin, a Potent Anticancer Indolocarbazole Alkaloid

ORGANIC LETTERS

IF5

2020-06-0218

PREAI

Libertellenone M, a diterpene derived from an endophytic fungus Phomopsis sp. S12, protects against DSS-induced colitis via inhibiting both nuclear translocation of NF-κB and NLRP3 inflammasome activation

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2020-03-0119

PREAI

Yan Shen

个人简介

教育背景

工作经历

荣誉奖项

研究方向